throbber

`
`COMMISSIONERS:
`
`and
`
`UNITED STATES OF AMERICA
`BEFORE THE FEDERAL TRADE COMMISSION
`
`Joseph J. Simons, Chairman
`Noah Joshua Phillips
`Rohit Chopra
`Rebecca Kelly Slaughter
`Christine S. Wilson
`
`________________________________________________
`
`In the Matter of
`
`BIONATROL HEALTH, LLC, a corporation,
`
`ISLE REVIVE, LLC, also d/b/a ISLE REVIVE CBD,
`
`a corporation,
`
`MARCELO TORRE, individually and as an owner
`
`and manager of BIONATROL HEALTH, LLC
`
`and ISLE REVIVE, LLC,
`
`
`
`ANTHONY MCCABE.
`
`________________________________________________
`
`
`
`202-3114
`
`
`
`
`
`DOCKET NO.
`
`COMPLAINT
`
`
`The Federal Trade Commission, having reason to believe that Bionatrol Health, LLC, a
`
`corporation, Isle Revive, LLC, also d/b/a Isle Revive CBD, a corporation, Marcelo Torre,
`individually and as an owner and manager of Bionatrol Health, LLC and Isle Revive, LLC, and
`Anthony McCabe (collectively, “Respondents”), have violated the provisions of the Federal
`Trade Commission Act, and it appearing to the Commission that this proceeding is in the public
`interest, alleges:
`
`Respondent Bionatrol Health, LLC (“Bionatrol”) is a Utah corporation with its principal
`1.
`place of business at 1269 W. Spencer Rd., Pleasant Grove, Utah 84062. Bionatrol’s business
`registration with the State of Utah expired on May 14, 2020.
`
`Respondent Isle Revive, LLC (“Isle Revive”), also doing business as Isle Revive CBD,
`2.
`is a Utah corporation with its principal place of business at 1269 W. Spencer Rd., Pleasant
`
`
`
`1
`
`

`

`Grove, Utah 84062. The company’s business registration status with the State of Utah is in a
`delinquent status. Isle Revive processed payments from consumers who purchased CBD
`products from Bionatrol and, as recently as April 2020, offered Bionatrol Full-Spectrum CBD
`Oil Extract for sale at www.islerevivecbd.com.
`
`
`Respondent Marcelo Torre has managed Bionatrol and serves as the company’s
`3.
`registered agent. Torre also has owned and managed Isle Revive. Individually or in concert with
`others, he controlled or had the authority to control, or participated in the acts and practices
`alleged in this complaint. Torre resides in Salt Lake City, Utah.
`
`
`Respondent Anthony McCabe was the manager and owner of Bionatrol. He also
`4.
`managed and owned part or all of Isle Revive. Individually or in concert with others, he
`controlled or had the authority to control, or participated in the acts and practices alleged in this
`complaint. McCabe resides in San Diego, California.
`
`Respondents Bionatrol and Isle Revive (collectively, “Corporate Respondents”) have
`5.
`operated as a common enterprise while engaging in the unlawful acts and practices alleged
`below. Corporate Respondents have conducted the business practices described below through
`an interrelated network of companies that have common ownership, officers, business functions,
`business and mailing addresses, and unified advertising and marketing. Because these Corporate
`Respondents have operated as a common enterprise, each of them is jointly and severally liable
`for the acts and practices alleged below. Respondents Torre and McCabe formulated, directed,
`controlled, had the authority to control, or participated in the acts and practices of the common
`enterprise alleged in this Complaint.
`
`The acts and practices of Respondents alleged in this complaint have been in or affecting
`6.
`commerce, as “commerce” is defined in Section 4 of the Federal Trade Commission Act.
`
`
`Respondents’ Marketing of CBD Products
`
`Cannabidiol (“CBD”) is a substance naturally occurring in, and that can be extracted
`7.
`from, the hemp plant, cannabis sativa. Respondents advertised, promoted, offered for sale, sold,
`and distributed products containing CBD (“CBD Products”) that are intended for human use.
`These CBD Products are “food” and/or “drugs,” within the meaning of Sections 12 and 15 of the
`Federal Trade Commission Act.
`
`Through the website bionatrolcbd.com, Respondents sold Full-Spectrum CBD Oil
`8.
`Extract in bundles of one, three, and five bottles for, respectively, $64.99 (plus $7.95 shipping),
`$149.97, and $199.95. During the ordering process, the website offered “upsells” for, among
`other things, one bottle of Full-Spectrum CBD Oil Extract Sleep Aid capsules at a cost of $49.99
`and one bottle of Full-Spectrum CBD Gummies at a cost of $54.95.
`
`From approximately December 2019 through April 2020, Respondents disseminated or
`9.
`caused to be disseminated advertisements for CBD Products, including but not necessarily
`limited to the attached Exhibits A through C. Respondents promoted CBD Products through a
`variety of means, including through their websites bionatrolcbd.com and islerevivecbd.com and
`
`
`
`2
`
`

`

`an Instagram account at www.instagram.com/bionatrol_cbd. These advertisements contained the
`following statements and depictions:
`
`[Ex. A (excerpt from www.bionatrolcbd.com) (captured Jan. 14, 2020)]
`# # #
`
`[Ex. A (excerpt from www.bionatrolcbd.com) (captured Jan. 14, 2020)]
`# # #
`
`3
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`THE SCIENCE OF
`CBD (CANNABIDOIL) [sic]
`The endocannabinoid system (ECS) regulates everything from relaxation to
`eating, sleeping, inflammation and even cognitive function…. CBD Oil has been
`medically proven to positively regulate your ECS addressing issues such as
`anxiety, insomnia, chronic pain, hypertension and even cardiovascular
`issues.
`
` •
`
` Physical Benefits: Stimulates an anti-inflammatory response which helps
`reduce all forms of chronic aches and pains. . . .
`
`• Psychological Benefits: Helps positively regulate mood patterns which help
`reduce anxiety and stress. It also promotes better sleep cycles and in some
`cases may offer a safe remedy for depression and bipolar disorders.
`
` •
`
` Neurological Benefits: Our CBD Oil’s positive impact on the neural system
`helps reduce age-related cognitive decline. It also helps support focus,
`alertness & memory recall while reducing the frequency of migraines and
`headaches.
`[Ex. A (excerpt from www.bionatrolcbd.com) (captured Jan. 14, 2020)]
`# # #
`
`[Ex. B (excerpt from www.bionatrolcbd.com, identified by Respondents as BIO00018)]
`
`4
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`# # #
`
`[Ex. C (partial screen grab from recording of purchase at www.bionatrolcbd.com on Jan.
`23, 2020, time index 0:14)]
`
`
`Respondents have not conducted any studies demonstrating that their CBD products cure,
`10.
`treat, alleviate, or prevent diseases or health conditions. There are no competent and reliable
`human clinical studies in the scientific literature to substantiate that these products or their
`ingredients cure, treat, mitigate, or prevent the diseases or health conditions mentioned in the
`advertising excerpts set forth in Paragraph 9
`
`Consumers who visited www.bionatrolcbd.com saw a webpage, a portion of which is
`11.
`depicted below, with the statements “Get My Free Bottle!” and “STEP 1 – TELL US WHERE
`TO SEND YOUR BOTTLE,” and a request for the consumers’ contact information.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`[Ex. C (partial screen grab from recording of purchase at www.bionatrolcbd.com on Jan.
`23, 2020, time index 0:01)]
`
`
`
`5
`
`

`

`
`After inputting the contact information and clicking the “Rush My Order” button for the
`12.
`free bottle of CBD oil, consumers were presented with a screen, a portion of which is depicted
`below, that stated, “APPROVED! Free Bottle Packages Confirmed” and presented three
`purchase options: “BUY 1 BOTTLE” for $64.99 plus $7.95 shipping, “BUY 2 + GET 1 FREE”
`for $149.97 and free shipping, or “BUY 3 + GET 2 FREE” for $199.95 and free shipping. The
`radial button next to the BUY 1 BOTTLE offer was prechecked, and consumers could not
`uncheck it. To advance the order, consumers had to input their name, address, and credit card
`information. A disclosure above the information fields stated, “You will see a charge on your
`credit card from Bionatrol….”
`
`
`
`[Ex. C (partial screen grab from recording of purchase at www.bionatrolcbd.com on Jan.
`23, 2020, time index 3:27-31 and 4:00-03)]
`
`
`
`
`6
`
`

`

`Clicking the “RUSH MY ORDER” button took consumers through a series of “upsell”
`13.
`offers for other products before they were presented with an order confirmation screen. That
`screen, a portion of which is depicted below, showed an image of a single bottle of CBD oil and
`provided no information about the quantity of bottles ordered or the amount, if any, charged to
`the consumers’ credit card.
`
`
`
`[Ex. C (partial screen grab from recording of purchase at www.bionatrolcbd.com on Jan.
`23, 2020, time index 5:50)]
`
`
`Upon completion of the ordering process for a single bottle, Respondents emailed
`14.
`consumers a purchase confirmation. The email memorialized the purchase of the “Bionatrol
`CBD Oil 3+2 Package” and indicated that Bionatrol had charged $199.95 to the consumer’s
`credit card. In at least one instance, the name listed on the credit card billing statement was “Isle
`Revive CBD.”
`
`
`Count I
`False or Unsubstantiated Efficacy Claims
`
`In connection with the advertising, promotion, offering for sale, sale, or distribution of
`15.
`CBD Products, including through the means described in Paragraph 9 of this Complaint,
`Respondents have represented, directly or indirectly, expressly or by implication, that CBD
`Products:
`
`
`A. treat, alleviate, or cure age-related cognitive decline; bipolar disorder; chronic pain,
`including arthritis pain; depression; heart disease; hypertension; and migraines;
`
`
`
`7
`
`

`

`B. prevent age-related cognitive decline; chronic pain, including arthritis pain; heart
`disease; hypertension; and migraines;
`
`C. can replace the need for prescription painkillers like oxycontin; and
`
`
`
`D. are safe for all consumers.
`
`
`The representations set forth in Paragraph 15 are false or misleading, or were not
`16.
`substantiated at the time the representations were made.
`
`
`Count II
`False Establishment Claims
`
`In connection with the advertising, promotion, offering for sale, sale, or distribution of
`17.
`CBD Products, including through the means described in Paragraph 9 of this Complaint,
`Respondents have represented, directly or indirectly, expressly or by implication, that studies or
`scientific research prove that CBD Products:
`
`
`A. improve alertness, focus, and memory recall;
`
`B. treat, alleviate, or cure age-related cognitive decline; anxiety; bipolar disorder;
`chronic pain, including arthritis pain; depression; heart disease; hypertension;
`inflammation; insomnia; and migraines; and
`
`
`C. prevent age-related cognitive decline; anxiety; chronic pain, including arthritis pain;
`heart disease; hypertension; inflammation; insomnia; and migraines.
`
`In fact, studies or scientific research do not prove that CBD Products:
`
`
`18.
`
`
`A. improve alertness, focus, and memory recall;
`
`
`B. treat, alleviate, or cure age-related cognitive decline; anxiety; bipolar disorder;
`chronic pain, including arthritis pain; depression; heart disease; hypertension;
`inflammation; insomnia; and migraines; and
`
`
`C. prevent age-related cognitive decline; anxiety; chronic pain, including arthritis pain;
`heart disease; hypertension; inflammation; insomnia; and migraines.
`
`Therefore, the representations set forth in Paragraph 17 are false or misleading.
`
`
`Count III
`Deceptive Pricing
`
`In connection with the advertising, promotion, offering for sale, sale, or distribution of
`19.
`CBD products, including through the means described in Paragraphs 11-14 of this Complaint,
`
`
`
`8
`
`

`

`Respondents represented, directly or indirectly, expressly or by implication, that they would send
`consumers one bottle of Full-Spectrum CBD Oil Extract for $64.99 plus $7.95 shipping.
`
`In fact, consumers who ordered one bottle of Full-Spectrum CBD Oil Extract were
`20.
`charged $199.95 and sent five bottles. Therefore, the representations set forth in Paragraph 19,
`above, are false or misleading.
`
`
`Count IV
`Unfairly Charging Consumers without Authorization
`
`In connection with the advertising, marketing, promotion, offering for sale, or sale of
`21.
`CBD products, including through the means described in Paragraphs 11-14 of this Complaint,
`Respondents have caused charges to be submitted for payment to the credit cards of consumers
`without the express informed consent of those consumers.
`
`Respondents’ actions caused or were likely to cause substantial injury to consumers that
`22.
`consumers could not reasonably avoid themselves and that was not outweighed by countervailing
`benefits to consumers or competition. Therefore, Respondents’ practices as described in
`Paragraph 21, above, constitute unfair acts or practices.
`
`
`Violations of Sections 5 and 12
`
`
`The acts and practices of Respondents as alleged in this complaint constitute unfair or
`23.
`deceptive acts or practices, and the making of false advertisements, in or affecting commerce in
`violation of Sections 5(a) and 12 of the Federal Trade Commission Act.
`
`
`THEREFORE, the Federal Trade Commission this _______ day of _______, 20__, has
`
`issued this Complaint against Respondents.
`
`
`
`
`
`
`
`
`
`SEAL:
`
`By the Commission.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`April J. Tabor
`Acting Secretary
`
`
`
`9
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket